Alessandra Girotti

Dr. Alessandra Girotti

BIOFORGE CIBER BBN UNIVERSITY OF VALLADOLID
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2004 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
Alessandra GirottiAlessandra Girotti
Alessandra Girotti
Javier RegueraJavier Reguera
Javier Reguera
JRJose Carlos Rodriguez-Cabello
Jose Carlos Rodriguez-Cabello
FAF. Javier Arias
F. Javier Arias
MAMatilde Alonso
Matilde Alonso
ATAna Ma Testera
Ana Ma Testera

1 February 2016 in Advanced Drug Delivery Reviews
Verified
Journal Article
Open access
JRJose Carlos Rodriguez-Cabello
Jose Carlos Rodriguez-Cabello
FAF. Javier Arias
F. Javier Arias
MRMatilde Alonso Rodrigo
Matilde Alonso Rodrigo
Alessandra GirottiAlessandra Girotti
Alessandra Girotti
The use of recombinant elastin-like materials, or elastin-like recombinamers (ELRs), in drug-delivery applications is reviewed in this work. Although ELRs were initially used in similar ways to other, more conventional kinds of polymeric carriers, their unique properties soon gave rise to systems of unparalleled functionality and efficiency, with the stimuli responsiveness of ELRs and their ability to self-assemble readily allowing the creation of advanced systems. However, their recombinant nature is likely the most important factor that has driven the current breakthrough properties of ELR-based delivery systems. Recombinant technology allows an unprecedented degree of complexity in macromolecular design and synthesis. In addition, recombinant materials easily incorporate any functional domain present in natural proteins. Therefore, ELR-based delivery systems can exhibit complex interactions with both their drug load and the tissues and cells towards which this load is directed. Selected examples, ranging from highly functional nanocarriers to macrodepots, will be presented.

1 April 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Juan Gonzalez-ValdiviesoJuan Gonzalez-Valdivieso
Juan Gonzalez-Valdivieso
Alessandra GirottiAlessandra Girotti
Alessandra Girotti
JSJose Schneider
Jose Schneider
FAFrancisco Javier Arias
Francisco Javier Arias

8 April 2004 in Macromolecules
Verified
Journal Article
Closed access
Alessandra GirottiAlessandra Girotti
Alessandra Girotti
Javier RegueraJavier Reguera
Javier Reguera
FAF. Javier Arias
F. Javier Arias
MAMatilde Alonso
Matilde Alonso
ATAna María Testera
Ana María Testera
JRJose Carlos Rodriguez-Cabello
Jose Carlos Rodriguez-Cabello

20 September 2011 in Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
Alessandra GirottiAlessandra Girotti
Alessandra Girotti
AFAlicia Fernández‐Colino
Alicia Fernández‐Colino
ILIsabel M. López
Isabel M. López
JRJose Carlos Rodriguez-Cabello
Jose Carlos Rodriguez-Cabello
FAF. Javier Arias
F. Javier Arias

1 October 2009 in Biomacromolecules
Verified
Journal Article
Closed access
Laura MartinmLaura Martinm
Laura Martinm
MAMatilde Alonso
Matilde Alonso
Alessandra GirottiAlessandra Girotti
Alessandra Girotti
FAF. Javier Arias
F. Javier Arias
JRJose Carlos Rodriguez-Cabello
Jose Carlos Rodriguez-Cabello